Clinical Trial Update: Pharmacokinetics and Dialyzability of Dapagliflozin in Dialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing pharmacokinetics and dialyzability of dapagliflozin in dialysis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: University of Campinas, Brazil | Conditions: End-stage Renal Disease | Phase 4 | Status: COMPLETED